Xenglu Lin 25/5mg Tablet – Maximum-Strength Empagliflozin + Linagliptin Dual Therapy for Type 2 Diabetes
Xenglu Lin 25/5mg Tablet – Maximum-Strength Empagliflozin + Linagliptin Dual Therapy for Type 2 Diabetes
Xenglu Lin 25/5mg Tablet – Maximum-Strength Empagliflozin + Linagliptin Dual Therapy for Type 2 Diabetes
Description
Xenglu Lin 25/5mg Tablet – High-Dose SGLT2 + DPP-4 Combo for Superior Glucose, Heart & Kidney Protection
Xenglu Lin 25/5mg Tablet combines the highest dose of empagliflozin 25mg (SGLT2 inhibitor) with linagliptin 5mg (DPP-4 inhibitor) in a single once-daily tablet. This powerful dual-action formula delivers exceptional A1C reduction, promotes greater weight loss, lowers blood pressure, and provides proven protection against heart failure, cardiovascular death, and diabetic kidney disease progression. Ideal for patients with established cardiovascular disease, chronic kidney disease, or those needing intensive glucose control beyond metformin or lower-dose therapies.
